Nucleic acid sample preparation instruments are advanced laboratory systems designed for the extraction, isolation, and purification of DNA and RNA from biological samples such as blood, tissue, and saliva. These instruments are essential for enabling downstream molecular applications, including PCR, next-generation sequencing (NGS), and gene expression analysis.
As the demand for precision diagnostics and personalized medicine continues to rise, the need for high-quality and reliable nucleic acid preparation has become increasingly critical. These instruments help ensure reproducibility, reduce contamination risks, and improve laboratory efficiency.
With the increasing prevalence of infectious diseases, cancer, and genetic disorders, laboratories are prioritizing efficient molecular testing workflows. Additionally, technological advancements are transforming the market, such as:
• Automated workflows
• Magnetic bead-based extraction
• Integrated sample-to-result systems
According to BIS Research, the nucleic acid sample preparation instruments market was valued at $910.1 million in 2024 and is projected to reach $1,601.8 million by 2035, growing at a CAGR of 5.10% during the forecast period 2025–2035.
Download the complete TOC and Request Sample Report
Key Drivers:
• Growing demand for molecular diagnostics in infectious diseases, oncology, and genetic testing
• Increasing adoption of automated and high-throughput sample preparation systems
• Rising use of next-generation sequencing (NGS), liquid biopsy, and biomarker analysis
• Expansion of genomics research and personalized medicine initiatives
• Increasing investments by pharmaceutical and biotechnology companies in R&D
• Advancements in technologies such as magnetic bead-based extraction and microfluidics
According to Principal Analyst at BIS Research:
“The nucleic acid sample preparation instruments market is set for strong growth as demand for molecular diagnostics and genomic testing continues to rise. Automated and high-throughput systems will play a central role in improving laboratory efficiency and scalability. With increasing investments in genomics, precision medicine, and pharmaceutical research, the market is expected to witness continuous innovation and adoption across clinical, research, and industrial applications.”
What is the expected growth outlook?
The market is projected to grow from $910.1 million in 2024 to $1,601.8 million by 2035, at a CAGR of 5.10% during 2025–2035.
Who are the key leaders in this market?
Key players include F. Hoffmann-La Roche AG, Promega Corporation, QIAGEN N.V., Thermo Fisher Scientific Inc., Tecan Trading AG, Eppendorf, Hamilton Company, Revvity, Inc. (PerkinElmer, Inc.), AutoGen Inc., and bioMérieux, Inc.
Which technologies are most in demand?
Magnetic bead-based extraction technologies dominate the market, while automated and integrated workflows are gaining traction due to their efficiency and scalability.
Want to Make Data-Backed Moves in the Life Sciences Market?
BIS Research provides expert-driven insights, granular segmentation, and strategic advisory across healthcare, life sciences, and emerging technology domains.
Request a sample report
Book a Preview
Download the complete TOC
